Home LiteratureArticle Details
PMID: 1985542 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Synthesis of type I collagen in healing wounds in humans.

Annals of surgery ·Vol. 213 ·No. 1 ·1991-01-00 ·Pages 75-80

Haukipuro K, Melkko J, Risteli L, Kairaluoma M, Risteli J

Abstract

To quantify wound healing in surgical patients, samples of wound fluid were collected through a silicone rubber tube for 7 postoperative days and their concentrations of the carboxyterminal propeptide of type I procollagen (PICP) and the aminoterminal propeptide of type III procollagen (PIIINP) were measured with specific radioimmunoassays. The mean concentration of PICP in would fluid on day 1 was 207 +/- 92 (SD) micrograms/L, and on day 2 908 +/- 469 micrograms/L (p less than 0.001, signed rank test). On day 7, the mean concentration reached was 380 times higher than that of day 1 (79,330 +/- 54,151 micrograms/L). Only one peak of PICP antigenicity, corresponding to the intact propeptide as set free during synthesis of type I procollagen, was detected on Sephacryl S-300 gel filtration analysis of wound fluid samples. The mean concentration of PIIINP was 70 +/- 61 micrograms/L on day 1, 86 +/- 88 micrograms/L on day 2, and 180 +/- 129 micrograms/L on day 3 (p less than 0.001 when compared with day 1). Finally on day 7, a 250-fold concentration (17,812 +/- 9839 micrograms/L), compared with day 1, was reached. Methods described in the present paper allow separate and repetitive quantification of the synthesis of both type I and type III procollagen during human wound healing.

MeSH Terms
Adult Aged Aged, 80 and over Colorectal Neoplasms/metabolism,physiopathology,surgery Exudates and Transudates/metabolism Female Humans Male Middle Aged Peptide Fragments/analysis,biosynthesis Procollagen/analysis,biosynthesis Specimen Handling Wound Healing
Chemicals
Peptide Fragments Procollagen procollagen Type III-N-terminal peptide procollagen type I carboxy terminal peptide
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Haukipuro K
Department of Surgery, University of Oulu, Finland.
Melkko J
Risteli L
Kairaluoma M
Risteli J
References (24)
24 references, click to expand
  1. Pepsin-solubilized collagens of guinea-pig dermis and dermal scar.
    Biochim Biophys Acta. 1974 Oct 9;365(2):454-7 PMID: 4609476
  2. Characterization of the collagen of human hypertrophic and normal scars.
    Biochim Biophys Acta. 1975 Oct 20;405(2):412-21 PMID: 1180964
  3. Collagen polymorphism in experimental granulation tissue.
    Biochem Biophys Res Commun. 1975 Oct 27;66(4):1160-5 PMID: 1191284
  4. Radioimmunoassay for human procollagen.
    Science. 1974 Dec 20;186(4169):1115-7 PMID: 4478921
  5. Presence of type III collagen in guinea-pig dermal scar.
    Biochem J. 1976 Jul 1;157(1):263-6 PMID: 962858
  6. Collagen types in early phases of wound healing in children.
    Acta Chir Scand. 1978;144(4):205-11 PMID: 360747
  7. The biosynthesis of collagen and its disorders (first of two parts).
    N Engl J Med. 1979 Jul 5;301(1):13-23 PMID: 449904
  8. Onset and localization of collagen synthesis during wound healing in open rat skin wounds.
    Proc Soc Exp Biol Med. 1979 Apr;160(4):458-62 PMID: 450911
  9. Quantitation of collagen types I and III during wound healing in rat skin.
    Proc Soc Exp Biol Med. 1979 Jul;161(3):337-40 PMID: 461460
  10. Sequential appearance of fibronectin and collagen in experimental granulation tissue.
    Lab Invest. 1980 Jul;43(1):47-51 PMID: 6993786
  11. Alterations in collagen production in mixed mononuclear leukocyte-fibroblast cultures.
    J Exp Med. 1983 Jan 1;157(1):47-59 PMID: 6549655
  12. Current concepts in soft connective tissue wound healing.
    Br J Surg. 1983 Mar;70(3):133-40 PMID: 6338989
  13. A possible mechanism for the regulation of collagen fibril diameter in vivo.
    Coll Relat Res. 1983 Jul;3(4):317-21 PMID: 6617133
  14. Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system.
    Dis Colon Rectum. 1984 Nov;27(11):707-13 PMID: 6499604
  15. Cutaneous tissue repair: basic biologic considerations. I.
    J Am Acad Dermatol. 1985 Nov;13(5 Pt 1):701-25 PMID: 2416789
  16. Early decrease in suture line breaking strength. The effect of proposed collagenase inhibition.
    Res Exp Med (Berl). 1985;185(6):451-5 PMID: 3003852
  17. Postoperative decrease in suture holding capacity in laparotomy wounds and anastomoses.
    Acta Chir Scand. 1985;151(6):533-5 PMID: 3911698
  18. Basic mechanisms in the healing cutaneous wound.
    J Dermatol Surg Oncol. 1986 Nov;12(11):1156-64 PMID: 3490500
  19. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass.
    Am J Physiol. 1987 Jan;252(1 Pt 1):C1-9 PMID: 3544859
  20. Aminoterminal propeptide of type III procollagen in healing wound in humans.
    Ann Surg. 1987 Dec;206(6):752-6 PMID: 3689011
  21. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.
    Clin Chem. 1988 Apr;34(4):715-8 PMID: 3359606
  22. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
    APMIS. 1988 Sep;96(9):793-804 PMID: 3048338
  23. Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings.
    Surgery. 1990 Apr;107(4):381-8 PMID: 2321135
  24. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.
    Clin Chem. 1990 Jul;36(7):1328-32 PMID: 2372946
Article Info
Journal
Annals of surgery
Abbr.
Ann Surg
ISSN
0003-4932
Published
1991-01-00
Pages
75-80
Language
English
Region
United States
NLM ID
0372354
PMCID
PMC1358314
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com